SUZ12 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SUZ12 monoclonal antibodies for research in epigenetics and gene regulation. SUZ12 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUZ12 is a critical component of the Polycomb Repressive Complex 2 (PRC2), which plays a vital role in the regulation of gene expression through histone modification. By mediating the trimethylation of histone H3 at lysine 27 (H3K27me3), SUZ12 is essential for maintaining cellular identity and controlling developmental processes. Dysregulation of SUZ12 has been implicated in various cancers and developmental disorders, making it a significant focus in both basic and translational research. Researchers can utilize SUZ12 monoclonal antibodies to explore chromatin modifications and their effects on gene expression. Understanding SUZ12's role in development and disease progression can lead to new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of epigenetic regulation and its impact on human health.